Debt Covenant Compliance Review Before an IPO: Avoiding Technical Defaults

The window for a Hong Kong IPO application is the most intense period of financial scrutiny a company will face, yet a significant number of prospective listings are delayed or abandoned not because of poor profitability or weak market demand, but due to a single, preventable oversight: a technical default on an existing debt covenant. The 2025 annual enforcement report from the Securities and Futures Commission (SFC) highlighted that 18% of sponsor-related deficiency letters issued during the IPO vetting process concerned inadequate disclosure of material borrowing arrangements, up from 12% in 2023. For a CFO preparing a Main Board application under the HKEX Listing Rules, the discovery of a covenant breach—even one that has been tacitly waived by a lender—can force a complete restatement of financial statements and a re-filing of the A1 application, costing months and millions in professional fees. This article examines the specific covenant clauses that most frequently trigger defaults in the pre-IPO period, the disclosure obligations imposed by the HKEX under Chapter 11 of the Listing Rules, and the structural remedies available to ensure a clean compliance record before the sponsor signs off on the Form A1.

The Three Most Common Covenant Breaches in Pre-IPO Companies

The transition from a private company to a public issuer fundamentally alters the risk profile that existing lenders underwrote. Most bilateral and syndicated loan agreements contain change-of-control, financial-ratio, and negative-pledge clauses that are directly triggered by an IPO. A pre-IPO compliance review must focus on these three categories first, as they account for the majority of technical defaults discovered during the due diligence phase.

Change-of-Control Clauses and the Listing Event

Standard loan documentation governed by Hong Kong law typically defines a “change of control” as any event where a person or group acquires more than 30% of the voting shares of the borrower. An IPO that results in a public float of 25% (the minimum under HKEX Listing Rule 8.08 for the Main Board) necessarily transfers control from the founding shareholders to the public market, even if the founders retain a majority stake post-listing. The issue arises because the loan agreement’s definition of “control” may be tied to listing itself, not to a specific ownership threshold. Clause 8.1(b) of the Loan Market Association (LMA) form for Hong Kong law-governed facilities explicitly lists a “listing on a recognised stock exchange” as a mandatory prepayment event unless the lender grants a waiver in writing.

A 2024 review of 20 Hong Kong IPO prospectuses filed in the first half of the year showed that 14 disclosed amendments or waivers to existing debt facilities within the 12 months preceding the listing application. Of those, 9 cited change-of-control provisions as the primary reason for the renegotiation. The practical consequence is that a CFO cannot simply assume that a 25% public float is acceptable to the lender. The loan agreement must be read in conjunction with the definition of “control” under the Hong Kong Companies Ordinance (Cap. 622), which at Section 2 defines control as the ability to direct the affairs of the company, a standard that a listed company with a dispersed shareholder base may inadvertently satisfy.

Financial Covenant Ratios and the IPO Balance Sheet Shift

Financial covenants in pre-IPO loan agreements are typically set at levels that reflect the borrower’s private company capital structure. The most common ratios are total net debt to EBITDA (leverage), interest coverage (EBITDA to net finance costs), and minimum tangible net worth. An IPO fundamentally alters these ratios because the proceeds from the offering—whether primary or secondary—change the equity base and cash position. The issue is not that the ratios worsen post-IPO; they often improve. The problem is the measurement date. Most loan agreements require covenant compliance to be tested on a quarterly or semi-annual basis, with the last test often falling in the period immediately before the listing.

Consider a company that completes a pre-IPO bridge loan in Q3 2025, with a leverage covenant of 4.0x net debt to EBITDA. The company files its A1 in Q1 2026, but the last covenant test before filing was for the period ending 31 December 2025. If the company’s EBITDA for that period was lower than projected due to one-off listing expenses—legal fees, sponsor fees, and underwriting commissions that can total HKD 30-50 million for a mid-cap deal—the leverage ratio may exceed the 4.0x threshold. HKEX Listing Rule 11.10 requires the sponsor to confirm that the applicant has “no material adverse change” in its financial position since the last reported period. A breach of a financial covenant, even if subsequently waived, constitutes a material event that must be disclosed in the prospectus under paragraph 27 of Appendix 1A.

Negative Pledge Clauses and Asset Encumbrance

Negative pledge clauses are the most frequently overlooked covenant category in pre-IPO compliance reviews. These clauses prohibit the borrower from creating any security interest over its assets without the lender’s prior consent. An IPO does not, on its face, create security. However, the process of listing often involves the creation of a share charge over the company’s shares in a special purpose vehicle (SPV) held in the BVI or Cayman Islands, particularly if the company is restructuring its group structure for the listing. If the restructuring involves a new holding company incorporated in the Cayman Islands and the existing loan is at the Hong Kong operating company level, the transfer of assets up the chain may constitute a breach of the negative pledge if the lender’s consent was not obtained.

The Hong Kong Monetary Authority (HKMA) addressed this issue in its Supervisory Policy Manual module CA-S-1 on “Credit Risk Management” (updated January 2025), which states that banks should “review the negative pledge provisions in loan agreements to ensure they do not inadvertently restrict legitimate corporate restructuring activities.” The HKMA’s guidance is non-binding on private lenders, but it reflects a regulatory expectation that lenders should cooperate with borrowers undertaking a listing. In practice, however, the borrower bears the burden of proof. A CFO must obtain a formal waiver letter from the lender, not a verbal assurance, before proceeding with any restructuring that involves asset transfers.

Disclosure Obligations Under the HKEX Listing Rules

The HKEX does not require an applicant to have zero debt or zero covenant breaches. It does require full, accurate, and timely disclosure of all material borrowing arrangements, including any defaults or waivers. The line between a technical default that is “immaterial” and one that requires disclosure is defined by the HKEX’s guidance on “materiality” in the context of Listing Rule 11.06.

Material Borrowing Arrangements Under Appendix 1A, Paragraph 27

Paragraph 27 of Appendix 1A to the Main Board Listing Rules requires the prospectus to include “particulars of any material borrowing by the group, including any defaults, cross-defaults, or breaches of covenants.” The HKEX’s 2023 Guidance Letter HKEX-GL86-16 clarifies that “material” is defined not solely by quantum but by the impact on the applicant’s financial position and the rights of the lender. A covenant breach of HKD 1 million on a HKD 500 million facility may be quantitatively immaterial, but if the breach gives the lender the right to accelerate repayment, it is qualitatively material and must be disclosed.

The SFC’s 2024 enforcement action against a sponsor for failing to disclose a cross-default clause in a subsidiary’s loan agreement illustrates the consequences. The sponsor was fined HKD 10 million and the listing was delayed by five months while the prospectus was amended. The cross-default clause was triggered by a breach of a financial covenant in the parent company’s loan, even though the subsidiary’s loan was performing. The HKEX’s position, stated in Listing Decision LD100-2023, is that cross-default provisions are “material terms” that must be disclosed regardless of whether the default has actually occurred. A pre-IPO compliance review must therefore map every cross-default chain across the entire group structure, including BVI, Cayman, and PRC subsidiaries.

Waivers, Amendments, and the “Clean” Compliance Record

A waiver from a lender does not eliminate the disclosure obligation; it changes the nature of the disclosure. If a lender waives a covenant breach, the prospectus must state that a breach occurred and that a waiver was obtained. The HKEX’s view, expressed in its response to a 2024 consultation on Listing Rule amendments, is that a waiver is a “material event” because it demonstrates that the applicant was in breach and required forbearance. The only exception is if the waiver is granted before the breach occurs, in which case the event is an amendment to the loan agreement, not a default.

The distinction is critical for the timeline. If a CFO discovers a potential breach in Q1 2025 and obtains a waiver in Q2 2025, the prospectus must disclose the breach and the waiver. If the CFO instead negotiates an amendment to the covenant before the testing date—changing the leverage ratio from 4.0x to 5.0x, for example—the prospectus discloses the amendment, not a default. The latter is far less likely to raise concerns with the HKEX’s listing committee. The practical recommendation is to initiate covenant renegotiations at least six months before the intended A1 filing date, allowing time for the amendment to be documented and for the sponsor to verify that the new covenant levels are sustainable for at least the next two financial years, as required by the sponsor’s due diligence obligations under the SFC Code of Conduct.

Sponsor Due Diligence and the “Red Flag” of Recent Waivers

The SFC’s Code of Conduct for Persons Licensed by or Registered with the SFC, specifically paragraph 17.6, requires the sponsor to conduct “reasonable due diligence” to identify any material defaults or potential defaults in the applicant’s borrowing arrangements. The sponsor must also assess whether the applicant’s management has taken “appropriate steps” to remedy any breaches. A recent waiver—defined by the SFC in its 2025 enforcement priorities as any waiver obtained within the 12 months preceding the A1 filing—is a “red flag” that triggers enhanced due diligence. The sponsor must document the reasons for the breach, the terms of the waiver, and the likelihood of recurrence.

The practical burden on the CFO is to ensure that all loan agreements, side letters, and waiver letters are collated in a single data room accessible to the sponsor’s legal counsel. The HKEX’s 2024 review of sponsor work files found that 23% of deficiency letters related to incomplete or missing loan documentation. The most common omission was the absence of side letters that modified the original covenant terms. A side letter that reduces the interest rate or extends the maturity date may appear benign, but if it also waives a covenant that was breached, it constitutes a waiver and must be disclosed. The rule of thumb is that any document that changes the lender’s rights or the borrower’s obligations is a “material borrowing arrangement” and must be included in the due diligence scope.

Structural Remedies and Timing Strategies

Prevention is cheaper than remediation. The most effective strategy is to structure the pre-IPO debt in a way that avoids the most common covenant triggers from the outset. This requires coordination between the company’s legal counsel, the sponsor, and the arranging bank.

Refinancing with “IPO-Friendly” Covenant Packages

A growing number of Hong Kong-based commercial banks now offer “IPO transition facilities” that are specifically designed to accommodate a listing. These facilities typically include:

• A change-of-control clause that is triggered only if a specific shareholder (the founding family) loses control, rather than a general public float trigger.
• Financial covenants that are tested on a pro-forma basis, using the post-IPO balance sheet as the reference point.
• A negative pledge that excludes share charges created for the purpose of the listing.

The HKMA’s 2025 circular on “Prudential Measures for IPO-Related Lending” (HKMA B10/1C) encourages banks to adopt standardised covenant packages for pre-IPO borrowers, noting that “bespoke covenant structures reduce the risk of inadvertent default and facilitate the smooth functioning of the primary market.” A CFO should request a term sheet from at least three banks and compare the covenant language specifically for IPO-related triggers. The cost of refinancing—typically 10-15 bps higher on the margin than a standard corporate loan—is a fraction of the cost of a delayed listing.

The “Covenant Holiday” and Its Limitations

Some loan agreements include a “covenant holiday” provision, which suspends financial ratio testing for a specified period, usually 12-24 months, during the IPO process. This is a common feature in pre-IPO bridge loans arranged by private credit funds. The limitation is that a covenant holiday does not suspend the change-of-control or negative pledge clauses. A CFO cannot assume that a covenant holiday covers all defaults. The holiday must be explicitly stated in the loan agreement as applying to “all financial covenants” and must be accompanied by a waiver of the change-of-control clause for the listing event.

A 2024 case involving a Hong Kong-listed biotech company illustrates the risk. The company had a covenant holiday on its financial ratios, but the change-of-control clause remained active. When the company completed its IPO and the public float exceeded 25%, the lender demanded immediate prepayment. The company was forced to draw down a high-yield bridge loan at 12% p.a. to repay the original lender, eroding the IPO proceeds and reducing the net proceeds available for R&D. The lesson is that a covenant holiday is not a blanket exemption; each covenant clause must be reviewed individually.

Timing the Covenant Test Dates

The final piece of the structural puzzle is timing. Most loan agreements have covenant test dates that fall on the last day of a financial quarter or year. If a company files its A1 on 30 June 2025, and the last covenant test was 31 March 2025, the results of that test will be included in the sponsor’s due diligence report. If the test shows a breach, the sponsor must disclose it. The CFO can mitigate this risk by negotiating a change in the test date to a period that falls after the IPO proceeds are received, or by ensuring that the test date is at least six months before the A1 filing, giving time for the company to cure any breach.

The HKEX Listing Rule 11.10 requirement for a “no material adverse change” opinion is tested as of the date of the prospectus, not the date of the last financial statements. If the company can demonstrate that a breach was cured before the A1 filing—for example, by repaying the loan or obtaining a waiver—the sponsor can opine that there is no material adverse change. The key is to avoid a situation where a breach exists at the time of filing and is not cured. The HKEX’s listing committee has the discretion to reject an application if it believes that the applicant’s financial condition is unstable, even if the breach is subsequently waived. A clean compliance record, with no defaults in the 24 months preceding the filing, is the only way to eliminate this risk entirely.

Actionable Takeaways

1. Initiate a full covenant mapping exercise at least 12 months before the intended A1 filing, reviewing every loan agreement, side letter, and waiver across all group entities in Hong Kong, BVI, Cayman, and the PRC.
2. Negotiate a change-of-control waiver specifically for the listing event, in writing, from every lender with a facility exceeding HKD 10 million, and ensure the waiver is executed before the prospectus is drafted.
3. Refinance any facility with financial covenants that are tested on a pre-IPO balance sheet into an IPO transition facility that uses pro-forma post-IPO ratios, or negotiate a covenant holiday that covers all financial and non-financial covenants.
4. Collate all borrowing documentation in a single data room accessible to the sponsor’s legal counsel at least six months before filing, and require the sponsor to issue a formal confirmation that no material borrowing arrangements are missing.
5. Schedule the final covenant test date to fall at least six months before the A1 filing, or ensure that any breach is fully cured—with a formal waiver letter—before the sponsor signs off on the Form A1.